Thomas Vallet
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development.
Journal: Viruses
Published: February 12, 2025
Chikungunya Virus RNA Secondary Structures Impact Defective Viral Genome Production.
Journal: Microorganisms
Published: July 14, 2024
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 12, 2023
Packaging, Purification, and Titration of Replication-Deficient Semliki Forest Virus-Derived Particles as a Self-Amplifying mRNA Vaccine Vector
Journal: Iranian biomedical journal
Published: April 26, 2022
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
Journal: EMBO reports
Published: November 15, 2021
APOBEC3C S188I Polymorphism Enhances Context-Specific Editing of Hepatitis B Virus Genome.
Journal: The Journal of infectious diseases
Published: August 28, 2021
An alphavirus-derived self-amplifying mRNA encoding PpSP15-LmSTI1 fusion protein for the design of a vaccine against leishmaniasis.
Journal: Parasitology international
Published: June 23, 2021
Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms.
Journal: Molecular and cellular probes
Published: May 05, 2021
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Journal: Nature communications
Published: April 27, 2021
Last Updated: 09/26/2026